Lutikizumab (ABT-981) is an anti-IL-1alpha and IL-1beta dual variable domain immunoglobulin. Lutikizumab binds and inhibits IL-1alpha and IL-1beta. Lutikizumab can be used for the research of osteoarthritis[1].
Molecular Weight:
(196.57 kDa)
Purity:
96.54
CAS Number:
[1791411-57-8]
Target:
Interleukin Related
Application Notes:
MCE Product type: Inhibitory Antibodies
* VAT and and shipping costs not included. Errors and price changes excepted